Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
12 2020
Historique:
received: 08 06 2020
revised: 28 07 2020
accepted: 30 07 2020
pubmed: 19 8 2020
medline: 22 12 2020
entrez: 19 8 2020
Statut: ppublish

Résumé

Given the high risk of infection-related mortality, patients with end-stage kidney disease (ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of patients with and without ESKD, hospitalized with COVID-19. This was a retrospective study of patients admitted with COVID-19 from 13 New York hospitals from March 1, 2020, to April 27, 2020, and followed through May 27, 2020. We measured primary outcome (in-hospital death), and secondary outcomes (mechanical ventilation and length of stay). Of 10,482 patients with COVID-19, 419 had ESKD. Patients with ESKD were older, had a greater percentage self-identified as Black, and more comorbid conditions. Patients with ESKD had a higher rate of in-hospital death than those without (31.7% vs 25.4%, odds ratio 1.38, 95% confidence interval 1.12 - 1.70). This increase rate remained after adjusting for demographic and comorbid conditions (adjusted odds ratio 1.37, 1.09 - 1.73). The odds of length of stay of seven or more days was higher in the group with compared to the group without ESKD in both the crude and adjusted analysis (1.62, 1.27 - 2.06; vs 1.57, 1.22 - 2.02, respectively). There was no difference in the odds of mechanical ventilation between the groups. Independent risk factors for in-hospital death for patients with ESKD were increased age, being on a ventilator, lymphopenia, blood urea nitrogen and serum ferritin. Black race was associated with a lower risk of death. Thus, among patients hospitalized with COVID-19, those with ESKD had a higher rate of in-hospital death compared to those without ESKD.

Identifiants

pubmed: 32810523
pii: S0085-2538(20)30945-5
doi: 10.1016/j.kint.2020.07.030
pmc: PMC7428720
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1530-1539

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK118017
Pays : United States

Investigateurs

Mersema Abate (M)
Hugo Paz Andrade (HP)
Richard L Barnett (RL)
Alessandro Bellucci (A)
Madhu C Bhaskaran (MC)
Antonio G Corona (AG)
Bessy Suyin Flores Chang (BS)
Mark Finger (M)
Steven Fishbane (S)
Michael Gitman (M)
Candice Halinski (C)
Shamir Hasan (S)
Azzour D Hazzan (AD)
Susana Hong (S)
Yuriy Khanin (Y)
Aireen Kuan (A)
Varun Madireddy (V)
Deepa Malieckal (D)
Abdulrahman Muzib (A)
Gayatri Nair (G)
Jia Hwei Ng (JH)
Rushang Parikh (R)
Daniel W Ross (DW)
Vipulbhai Sakhiya (V)
Mala Sachdeva (M)
Richard Schwarz (R)
Hitesh H Shah (HH)
Purva Sharma (P)
Pravin C Singhal (PC)
Nupur N Uppal (NN)
Rimda Wanchoo (R)
Jamie S Hirsch (JS)
Kenar D Jhaveri (KD)
Vinay V Nair (VV)

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

Kidney Int. 2015 Jan;87(1):169-75
pubmed: 25029429
J Am Soc Nephrol. 1993 Mar;3(9):1613-22
pubmed: 8507818
Kidney Int Rep. 2020 May 24;5(7):1095-1099
pubmed: 32642606
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Lancet. 2020 Apr 4;395(10230):1137-1144
pubmed: 32178768
Kidney Int. 2020 Jul;98(1):209-218
pubmed: 32416116
Kidney Int. 2020 Jul;98(1):27-34
pubmed: 32437770
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
Circulation. 2019 Sep 17;140(12):1031-1040
pubmed: 31337231
J Am Soc Nephrol. 2020 Sep;31(9):1948-1958
pubmed: 32660970
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
J Am Soc Nephrol. 2020 Aug;31(8):1815-1823
pubmed: 32561681
Leukemia. 2020 Aug;34(8):2173-2183
pubmed: 32546725
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Adv Ren Replace Ther. 1997 Jan;4(1):3-12
pubmed: 8996615
Nephrol Dial Transplant. 2013 Nov;28(11):2687-97
pubmed: 23956234
Can J Kidney Health Dis. 2019 Apr 29;6:2054358119839080
pubmed: 31065378
Kidney Int. 2000 Sep;58(3):1293-9
pubmed: 10972693
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769
pubmed: 28572159
Dis Markers. 2013;35(6):791-8
pubmed: 24347799
Can J Kidney Health Dis. 2015 Sep 08;2:34
pubmed: 26351568
Cytokine Growth Factor Rev. 2020 Jun;53:66-70
pubmed: 32418715
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Am J Kidney Dis. 2019 Jun;73(6):765-776
pubmed: 30738630
Kidney Int. 2000 Oct;58(4):1758-64
pubmed: 11012910
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397
pubmed: 32385130
JAMA. 2011 Aug 10;306(6):620-6
pubmed: 21828325
Hypertension. 2020 Feb;75(2):483-491
pubmed: 31838905
Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99
pubmed: 17699392
Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244
pubmed: 30010940
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Proc (Bayl Univ Med Cent). 2008 Oct;21(4):363-72
pubmed: 18982076
J Am Soc Nephrol. 2010 Aug;21(8):1361-9
pubmed: 20651163
J Gen Intern Med. 2020 Oct;35(10):3097-3099
pubmed: 32754782
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415
pubmed: 32467113
Int J Infect Dis. 2020 Jul;96:467-474
pubmed: 32425643
Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33
pubmed: 18701615
Clin Nephrol. 2020 Jul;94(1):11-13
pubmed: 32452757
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Kidney Int. 2020 Jul;98(1):20-26
pubmed: 32437768
Am J Nephrol. 2014;39(3):183-94
pubmed: 24556752
Kidney Int. 2020 Jul;98(1):235-236
pubmed: 32471636
J Am Soc Nephrol. 2019 Feb;30(2):346-353
pubmed: 30679380
Multidiscip Respir Med. 2012 Nov 21;7(1):47
pubmed: 23171626
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Clin Exp Immunol. 2018 May;192(2):142-150
pubmed: 29453850
J Am Soc Nephrol. 1994 Nov;5(5):1231-42
pubmed: 7873734
Nephrol Dial Transplant. 2013 Sep;28(9):2287-94
pubmed: 23535224
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Jia H Ng (JH)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Jamie S Hirsch (JS)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Manhasset, New York, USA; Department of Information Services, Northwell Health, New Hyde Park, New York, USA.

Rimda Wanchoo (R)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Mala Sachdeva (M)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Vipulbhai Sakhiya (V)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Susana Hong (S)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Kenar D Jhaveri (KD)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Steven Fishbane (S)

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA. Electronic address: sfishbane@northwell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH